Level Bio AB (publ) (NGM:LEVBIO)
Sweden · Delayed Price · Currency is SEK 0.2540
-0.0360 (-12.41%)
At close: Jun 12, 2026
Level Bio AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 33.55 | 32.36 | 25.1 | 26.1 | 34.33 | 43.96 |
Other Revenue | -0 | -0 | - | - | - | - |
| 33.55 | 32.36 | 25.1 | 26.1 | 34.33 | 43.96 | |
Revenue Growth (YoY) | 22.43% | 28.94% | -3.83% | -23.99% | -21.91% | 86.86% |
Cost of Revenue | 15.55 | 15.31 | 11.6 | 13.79 | 19.08 | 26.08 |
Gross Profit | 17.99 | 17.06 | 13.49 | 12.31 | 15.25 | 17.88 |
Selling, General & Admin | 18.42 | 18.24 | 19.6 | 20.33 | 15.87 | 12.05 |
Other Operating Expenses | 0.11 | 0.11 | -0.21 | -0.48 | -0.46 | -0.69 |
Operating Expenses | 20.7 | 20.54 | 21.58 | 22.04 | 17.59 | 12.62 |
Operating Income | -2.71 | -3.49 | -8.08 | -9.73 | -2.33 | 5.26 |
Interest Expense | -0.1 | -0.08 | -0.13 | -0.01 | -0.08 | -0.04 |
Interest & Investment Income | - | - | 0.02 | 0.05 | 0 | - |
Other Non Operating Income (Expenses) | 0 | 0 | - | - | - | - |
EBT Excluding Unusual Items | -2.81 | -3.57 | -8.19 | -9.69 | -2.41 | 5.21 |
Pretax Income | -2.81 | -3.57 | -8.19 | -9.69 | -2.41 | 5.21 |
Income Tax Expense | 0.06 | -0.03 | -0.32 | -0.22 | -0.19 | 0.06 |
Net Income | -2.87 | -3.54 | -7.87 | -9.48 | -2.22 | 5.16 |
Net Income to Common | -2.87 | -3.54 | -7.87 | -9.48 | -2.22 | 5.16 |
Net Income Growth | - | - | - | - | - | 240.69% |
Shares Outstanding (Basic) | 68 | 68 | 63 | 63 | 63 | 59 |
Shares Outstanding (Diluted) | 68 | 68 | 65 | 63 | 63 | 63 |
Shares Change (YoY) | 5.80% | 4.79% | 2.96% | - | - | 20.00% |
EPS (Basic) | -0.04 | -0.05 | -0.12 | -0.15 | -0.04 | 0.09 |
EPS (Diluted) | -0.04 | -0.05 | -0.12 | -0.15 | -0.04 | 0.08 |
EPS Growth | - | - | - | - | - | 179.27% |
Free Cash Flow | -0.54 | 0.82 | -4.46 | -5.49 | 2.79 | 1.63 |
Free Cash Flow Per Share | -0.01 | 0.01 | -0.07 | -0.09 | 0.04 | 0.03 |
Gross Margin | 53.63% | 52.70% | 53.77% | 47.16% | 44.43% | 40.67% |
Operating Margin | -8.08% | -10.78% | -32.21% | -37.30% | -6.79% | 11.96% |
Profit Margin | -8.56% | -10.94% | -31.37% | -36.31% | -6.48% | 11.73% |
Free Cash Flow Margin | -1.60% | 2.53% | -17.78% | -21.03% | 8.14% | 3.70% |
EBITDA | -0.53 | -1.3 | -6.94 | -8.58 | -1.19 | 5.91 |
EBITDA Margin | -1.58% | -4.01% | -27.65% | -32.87% | -3.48% | 13.45% |
D&A For EBITDA | 2.18 | 2.19 | 1.14 | 1.15 | 1.14 | 0.65 |
EBIT | -2.71 | -3.49 | -8.08 | -9.73 | -2.33 | 5.26 |
EBIT Margin | -8.08% | -10.78% | -32.21% | -37.30% | -6.79% | 11.96% |
Effective Tax Rate | - | - | - | - | - | 1.09% |
Revenue as Reported | 33.81 | 32.49 | 25.18 | 26.67 | 34.68 | 44.65 |